Inventor · disambiguated record
Christel Larbouret
Also filed as: LARBOURET CHRISTEL
9 granted patents·3 pending applications·7 citations·filing 2006–2023
78Inventor score
Files withINST NAT SANTE RECH MED3BIOMUNEX PHARMACEUTICALS2ROBERT BRUNO2CHARDES THIERRY1GAMAMABS PHARMA1
Top patents by PatentIndex Score
12 records- 0175US9127065B2Anti-human HER3 antibodies and uses thereofCHARDES THIERRY·Filed 2012·Granted Sep 8, 2015·5 cites·13 claims
- 0265US9409988B2Anti-Axl antibodies and uses thereofROBERT BRUNO·Filed 2012·Granted Aug 9, 2016·1 cites·17 claims
- 0361US9249228B2Anti-Axl antibodies and uses thereofROBERT BRUNO·Filed 2012·Granted Feb 2, 2016·1 cites·15 claims
- 0457US2025282892A1Bispecific antibodies binding to her-3 and to either her-2 or egfrBIOMUNEX PHARMACEUTICALS·Filed 2023·Application pending·0 cites
- 0548US10196455B2Neuregulin allosteric anti-HER3 antibodyINST NAT SANTE RECH MED·Filed 2013·Granted Feb 5, 2019·0 cites·14 claims
- 0648US9522956B2Combination therapy using anti-EGFR and anti-HER2 antibodiesL'INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE·Filed 2014·Granted Dec 20, 2016·0 cites·15 claims
- 0746US2009214541A1Combination Therapy Using Anti-EGFR and Anti-HER2 AntibodiesINSTUT NAT DE LA SANTE ET DE L·Filed 2006·Application pending·0 cites
- 0837US2018291098A1Anti-nrg1 (heregulin) antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2016·Application pending·0 cites
- 0936US12054550B2Bispecific antibodies targeting EGFR and HER2BIOMUNEX PHARMACEUTICALS·Filed 2017·Granted Aug 6, 2024·0 cites·10 claims
- 1035US10398774B2Human monoclonal antibodies against AXLINST NAT SANTE RECH MED·Filed 2015·Granted Sep 3, 2019·0 cites·14 claims
- 1134US9346883B2Antibodies against HER3KHARRAT ABDELHAKIM·Filed 2012·Granted May 24, 2016·0 cites·12 claims
- 1233US11001634B2Anti-human-HER3 antibodies and uses thereofGAMAMABS PHARMA·Filed 2016·Granted May 11, 2021·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Christel Larbouret files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →